Reduced plasmacytoid dendritic cell output is associated with high risk in low-grade myelodysplastic syndrome Research Letter
| Authors: | Chan, A.; Liu, Y.; Devlin, S.; Gao, Q.; Baik, J.; Sigler, A.; Londono, D.; Arcila, M.; Levine, R.; Dogan, A.; Zhang, Y.; Roshal, M.; Xiao, W. |
| Title: | Reduced plasmacytoid dendritic cell output is associated with high risk in low-grade myelodysplastic syndrome |
| Keywords: | adult; cancer chemotherapy; controlled study; survival analysis; human cell; major clinical study; overall survival; comparative study; cancer staging; flow cytometry; outcome assessment; follow up; antineoplastic agent; letter; antigen expression; disease association; progression free survival; patient monitoring; risk assessment; b cell lymphoma; myelodysplastic syndrome; proportional hazards model; cell culture; control group; hla dr antigen; high risk population; leukocyte; bone marrow examination; plasmacytoid dendritic cell; acute myeloid leukemia; low risk population; cd123 antigen; human; receptor type tyrosine protein phosphatase c; refractory cytopenia with unilineage dysplasia |
| Journal Title: | HemaSphere |
| Volume: | 6 |
| Issue: | 2 |
| ISSN: | 2572-9241 |
| Publisher: | Lippincott Williams & Wilkins |
| Date Published: | 2022-02-01 |
| Start Page: | e685 |
| Language: | English |
| DOI: | 10.1097/hs9.0000000000000685 |
| PROVIDER: | scopus |
| PMCID: | PMC8815631 |
| PUBMED: | 35136856 |
| DOI/URL: | |
| Notes: | Letter -- Export Date: 1 March 2022 -- Source: Scopus |
